Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization

Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype

(2011) A. W. Tarr et al.   JOURNAL OF VIROLOGY

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

(2010) Samira Fafi-Kremer et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection

(2010) L. Liu et al.   JOURNAL OF VIROLOGY

Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission

(2010) C. L. Brimacombe et al.   JOURNAL OF VIROLOGY

Selection Pressure From Neutralizing Antibodies Drives Sequence Evolution During Acute Infection With Hepatitis C Virus

(2009) Kimberly A. Dowd et al.   GASTROENTEROLOGY

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

(2009) Alexander Ploss et al.   NATURE

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

(2009) Nicasio Mancini et al.   PLoS One

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

(2009) P. Zhang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles

(2009) Wanyin Tao et al.   VIROLOGY

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs

(2008) Judith M. Gottwein et al.   HEPATOLOGY

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

(2008) A. M. Owsianka et al.   JOURNAL OF GENERAL VIROLOGY

CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells

(2008) J. Witteveldt et al.   JOURNAL OF GENERAL VIROLOGY

Identification of a Residue in Hepatitis C Virus E2 Glycoprotein That Determines Scavenger Receptor BI and CD81 Receptor Dependency and Sensitivity to Neutralizing Antibodies

(2008) J. Grove et al.   JOURNAL OF VIROLOGY

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

(2008) Z.-Y. Keck et al.   JOURNAL OF VIROLOGY